Friends,
Forgive me for my lack of posting. I have been living out of a suitcase for more than a month now. Please take a look at my latest post, an interview with Dr. Farooqui out of the NIH that shares important news about research at the NIH, ABT-199, and also my personal news.
Stay strong
Many thanks Brian for the Blog update, great videos.
Your forgiveness is automatic.
Great to see continued good news on the ABT-199 comeback, and the possibilities with that.
And the very best of luck with the refocussing of the lecturing activities.
Best Regards,
Ernest.
Informative interview and video. Thank you for posting.
ASH 2013: Dr. John Pagel Discusses Radio-Immune Therapy (RIT) in Chronic Lymphocytic Leukemia (CLL)Acalabrutinib Plus Venetoclax and Obinutuzumab Achieves High Bone Marrow uMRD Rate in Chronic Lymphocytic Leukemia - CLLOver nine years of blogging since transplant for CLL (chronic lymphocytic leukemia) on July 1, 2008ASCO 2014: Dr. Susan O'Brien Reviews the 3 years follow-up Data on Ibrutinib in CLL
Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies
